Mark Bergen and David Ramli, writing for Bloomberg:
DeepMind, the AI lab of Google’s Alphabet Inc., has labored for nearly two years to access medical records from the U.K.’s National Health Service for a diagnostics app. The agency began a trial with the company using 1.6 million patient records. Last month, the top U.K. privacy watchdog declared the trial violates British data-protection laws, throwing its future into question.
Contrast that with how officials handled a project in Fuzhou. Government leaders from that southeastern Chinese city of more than seven million people held an event on June 26. Venture capital firm Sequoia Capital helped organize the event, which included representatives from Dell Inc., International Business Machines Corp. and Lenovo Group Ltd. A spokeswoman for Dell characterized the event as the nation’s first "Healthcare and Medical Big Data Ecology Summit."
The summit involved a vast handover of data. At the press conference, city officials shared 80 exabytes worth of heart ultrasound videos, according to one company that participated. With the massive data set, some of the companies were tasked with building an AI tool that could identify heart disease, ideally at rates above medical experts. They were asked to turn it around by the fall.
This is data on a scale that the US and UK seemingly would never agree to data owners sharing with any private corporation. Though I wonder if university researchers could do so.